{
  "paper_id": "97e97f0673863b6f5fed52b843f554bc66e85eea",
  "metadata": {
    "title": "",
    "coda_data_split": "train",
    "coda_paper_id": 9444,
    "coda_has_expert_labels": false,
    "subset": "custom_license"
  },
  "abstract": [
    {
      "original_text": "publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.",
      "sentences": [
        [
          {
            "segment_text": "publicly funded repositories , such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source .",
            "crowd_label": "background"
          }
        ],
        [
          {
            "segment_text": "These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active .",
            "crowd_label": "background"
          }
        ]
      ]
    },
    {
      "original_text": "Preliminary communication 2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV)",
      "sentences": [
        [
          {
            "segment_text": "Preliminary communication 2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus ( HCV ) and SARS-associated coronavirus ( SCV )",
            "crowd_label": "finding"
          }
        ]
      ]
    }
  ],
  "abstract_stats": {
    "paragraph_num": "2",
    "sentence_num": "3",
    "segment_num": "3",
    "token_num": "71"
  }
}